Systematic review and meta-analysis of observational studies (2013–2023) in adult statin users: pooled residual MACE or all-cause death rate 12.3 per 1000 person-years, 6.4 in those at risk and 15.8 in those with prior ASCVD; between-study variability was substantial.
Meta-analysis
Watanabe et al. Residual Atherosclerotic Cardiovascular Disease Risk in Statin Users: A Systematic Review and Meta-Analysis